James Poyitt, a 16 year old school student visited Vestech, along with his father Stewart Poyitt for advice on his innovative leg rehabilitation device. James had been selected to present his invention in Phoenix Arizona at the Intel International Science and Technology Fair – a huge honour. Vestech’s Dr Roger assisted them with weighing up the […]
Dr Carlotta Duncan, the Director for Scientific Advancement at the Buck Institute for Research on Ageing, gave Vestech’s CEO, Dr Greg Roger a tour of the Institute’s facility in Novato California.
The time is now for Australia to take definitive steps to promote a thriving Medical Device sector which employs people, creates wealth and improves Australia’s future in a competitive world. CSL’s decision to locate a new plant in Switzerland speaks to the need for the AIM Tax Incentive, which has been clearly shown.
Vestech headlined the Medical Devices Seminar, sponsored by ICN WA, on August 12th, 2014. Attendees from across industry heard from Vestech’s CEO, Dr Greg Roger, as well as Dr Cheryl McRae of the TGA, James Brennan of Design and Industry and Dr Stewart Washer of Cynata Therapuetics.
Removing bureaucratic hurdles, through the JOBS Act in the US, has been shown to directly stimulate commercialisation of innovation.
estech’s CEO, Dr Greg Roger, will be chairing a seminar in Perth August 12 for ICN. This seminar, covering Regulatory Issues and Commercialisation Essentials is a development from the two seminars held in Sydney and Melbourne in MAy and June this year as part of the Federal Government’s Advocate Program.
In today’s Financial Review (7 July, 2014) Tim Dodd has written about the challenges in STEM teaching facing Australia (Why the next Zuckerberg won’t be Australian). Quoting Dr Nick Cerneaz, executive director of the Warren Centre for Advanced Engineering, the article has picked up on the future growth of our economy and how a poor STEM capability will inevitably crimp that growth.